Clinical Trial Update: Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies

View source ↗

Summary

This document provides an update on a clinical trial focused on integrated multiomics and multilevel characterization of hematologic disorders and malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Disease
• Hematological Malignancy

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Haematologic Disease, Haematological Malignancy | Status: UNKNOWN